Cancer Health Treatment Update Two Kinds of Acupuncture Relieve Chronic Cancer Pain Better Than Drugs Acupuncture was associated with a steeper and more sustained reduction in chronic pain for cancer survivors than pain medications. FDA Approves New CAR-T Therapy for Multiple Myeloma More than 70% of people treated with Abecma, a customized immunotherapy, experienced complete or partial remission. New Lung Cancer Screening Recommendation Expands Eligibility The update ensures that more minorities and women with lighter smoking histories now qualify for screening. Studies Suggest Diet Can Help Breast Cancer Survivors Live Longer Those who eat a diet high in vegetables and fiber and low in fruit juice and certain carbohydrates have a lower risk of dying. Advertisement Can Vaccination and Infection Rates Add Up to Reach COVID Herd Immunity? While the United States is getting closer to this point, most health experts caution, it still has ground to cover. More News About COVID-19 For more news about the novel coronavirus and COVID-19, including how it affects people living with cancer, visit our sister site, COVID Health.com. Cancer Health Spring 2021 Check out our latest print edition! Newsfeed Two New Studies Suggest Diet Can Help Breast Cancer Survivors Live Longer ER-Positive Breast Cancer: What’s the Latest in Treatment? Ukrainian Traffickers Sentenced for Counterfeit Cancer and Hepatitis Drugs Four Ways the $1.9 Trillion COVID-19 Relief Plan Boosts Obamacare Blog: Food and Drug Administration (FDA) FDA Approves Yescarta for Follicular Lymphoma FDA Approves Lorbrena for Metastatic ALK-Positive Lung Cancer FDA Approved Pepaxto for Heavily Treated Multiple Myeloma FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy Newsfeed Two New Studies Suggest Diet Can Help Breast Cancer Survivors Live Longer ER-Positive Breast Cancer: What’s the Latest in Treatment? Ukrainian Traffickers Sentenced for Counterfeit Cancer and Hepatitis Drugs Four Ways the $1.9 Trillion COVID-19 Relief Plan Boosts Obamacare Blog: Food and Drug Administration (FDA) FDA Approves Yescarta for Follicular Lymphoma FDA Approves Lorbrena for Metastatic ALK-Positive Lung Cancer FDA Approved Pepaxto for Heavily Treated Multiple Myeloma FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: